Good investing reading Fresenius Kabi Oncology’s OFS and delisting – minority shareholders skewered Companies where promoters had a stake that was higher than 75% had to satisfy SEBI’s norms of promoter stake being not more than 75% by June 2013. There are 2 options for promoters. Either buy the remaining stake from the minority shareholders […]